Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)
- Citation:
- Oncologist vol 27 (5) 338-e368
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- collection
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 11
- Parents:
- 341
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA232760
- Corr. Author:
- Authors:
- Kostandinos Sideras David W Hillman Karthik Giridhar Brenda F Ginos Richard C Tenglin Heshan Liu Beiyun Chen Winston Tan Gerald G Gross Rex B Mowat Amylou C Dueck Edith A Perez Alvaro Moreno-Aspitia
- Networks:
- LAPS-MN026, OH016, PR028, SANFORD
- Study
- NCCTG-N1031
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- pixantrone, breast cancer, anthracycline, randomized phase II, cardiotoxicity